HOW DOES HEMODYNAMIC REGULATION AFFECTS GRAFT FUNCTIONS DURING RENAL TRANSPLANTATION?

• Sponsor: Ankara City Hospital Bilkent (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT05753475
• Collaborator: (none)
• Enrollment: 100
• Location: 1
• Anticipated Duration (Months): 11.1
• Patients Per Site Per Month: 9

Study Details

Study Description

Brief Summary

The aim of the researchers was to evaluate the adequacy of graft function in the postoperative period of patients who underwent renal transplantation and encountered hypotension in the intraoperative period.

Condition or Disease	Intervention/Treatment	Phase
Renal Transplant Failure and Rejection; Hypotension	Other: renal transplantation

Study Design

• Study Type: Observational [Patient Registry]
• Anticipated Enrollment: 100 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: DOES HEMODYNAMIC REGULATION AFFECTS GRAFT FUNCTIONS DURING RENAL TRANSPLANT?
• Anticipated Study Start Date: Mar 1, 2023
• Anticipated Primary Completion Date: Apr 1, 2023
• Anticipated Study Completion Date: Feb 1, 2024

Arms and Interventions

Arm	Intervention/Treatment
hypotension	Other: renal transplantation; patients undergoing renal transplantation
normotension	Other: renal transplantation; patients undergoing renal transplantation

Outcome Measures

Primary Outcome Measures

1. Systolic Blood Pressure [baseline]

2. Mean Arterial Pressure [baseline]

3. Systolic Blood Pressure [during the surgery]

4. Mean Arterial Pressure [during the surgery]

5. graft function [immediately after the surgery]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 12 Years to 80 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• patients undergoing renal transplantation

Exclusion Criteria:

• patient refusal

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Ankara City Hospital	Ankara		Turkey	06800

Sponsors and Collaborators

• Ankara City Hospital Bilkent

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: ismail aytaç, Principal investigator, Ankara City Hospital Bilkent
• ClinicalTrials.gov Identifier: NCT05753475
• Other Study ID Numbers: E1-23-3249
• First Posted: Mar 3, 2023
• Last Update Posted: Mar 3, 2023
• Last Verified: Mar 1, 2023

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Hypotension

Study Results

No Results Posted as of Mar 3, 2023